DK3482771T3 - Fremstilling af jordnøddeformuleringer til oral desensibilisering - Google Patents

Fremstilling af jordnøddeformuleringer til oral desensibilisering Download PDF

Info

Publication number: DK3482771T3
Authority: DK; Denmark
Prior art keywords: preparation; oral desensitization; peanut; formulations; peanut formulations
Prior art date: 2013-03-14

Application number

DK18213124.3T

Other languages

English (en)

Inventor

Bryan Walser

Howard V Raff

Original Assignee

Nestle Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2013-03-14

Filing date

2014-03-12

Publication date

2023-03-20

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=51528061&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK3482771(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2014-03-12 Application filed by Nestle Sa filed Critical Nestle Sa

2023-03-20 Application granted granted Critical

2023-03-20 Publication of DK3482771T3 publication Critical patent/DK3482771T3/da

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
- A61J3/07—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4833—Encapsulating processes; Filling of capsules
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4875—Compounds of unknown constitution, e.g. material from plants or animals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Immunology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Natural Medicines & Medicinal Plants (AREA)
Microbiology (AREA)
Mycology (AREA)
Botany (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Zoology (AREA)
Medical Informatics (AREA)
Pulmonology (AREA)
Alternative & Traditional Medicine (AREA)
Biotechnology (AREA)
Transplantation (AREA)
Medicinal Preparation (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines Containing Plant Substances (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Cosmetics (AREA)

DK18213124.3T 2013-03-14 2014-03-12 Fremstilling af jordnøddeformuleringer til oral desensibilisering DK3482771T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US201361784964P	2013-03-14	2013-03-14
EP14776121.7A EP2968529B1 (en)	2013-03-14	2014-03-12	Manufacture of peanut formulations for oral desensitization

Publications (1)

Publication Number	Publication Date
DK3482771T3 true DK3482771T3 (da)	2023-03-20

Family

ID=51528061

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DK14776121.7T DK2968529T3 (da)	2013-03-14	2014-03-12	Fremstilling af jordnøddeformuleringer til oral desensibilisering
DK18213124.3T DK3482771T3 (da)	2013-03-14	2014-03-12	Fremstilling af jordnøddeformuleringer til oral desensibilisering

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
DK14776121.7T DK2968529T3 (da)	2013-03-14	2014-03-12	Fremstilling af jordnøddeformuleringer til oral desensibilisering

Country Status (18)

Country	Link
US (5)	US9198869B2 (da)
EP (3)	EP3482771B1 (da)
JP (3)	JP6752140B2 (da)
CN (2)	CN105101994B (da)
AU (5)	AU2014240404B2 (da)
BR (1)	BR112015021756B1 (da)
CA (1)	CA2903229A1 (da)
DK (2)	DK2968529T3 (da)
ES (2)	ES2940686T3 (da)
FI (2)	FI3482771T3 (da)
FR (1)	FR23C1026I2 (da)
HK (1)	HK1217660A1 (da)
HU (1)	HUE051831T2 (da)
MX (1)	MX2015010315A (da)
PL (1)	PL2968529T3 (da)
PT (1)	PT2968529T (da)
SI (1)	SI2968529T1 (da)
WO (1)	WO2014159607A1 (da)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2924349B1 (fr)	2007-12-03	2010-01-01	Dbv Tech	Methode de desensibilitation aux allergenes
US9492535B2 (en)	2013-03-14	2016-11-15	Aimmune Therapeutics, Inc.	Peanut formulations and uses thereof
FI3482771T3 (fi)	2013-03-14	2023-04-03	Nestle Sa	Maapähkinäformulaatioiden valmistaminen oraaliseen siedätyshoitoon
KR102425265B1 (ko)	2014-08-25	2022-07-26	에이뮨 테라퓨틱스, 인코퍼레이티드	난 단백질 제형 및 이의 제조 방법
MA41020A (fr)	2014-11-25	2017-10-03	Evelo Biosciences Inc	Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
US10166286B2 (en)	2015-02-20	2019-01-01	The Board Of Trustees Of The Leland Stanford Junior University	Mixed allergen compositions and methods for using the same
US10149904B2 (en)	2015-02-20	2018-12-11	The Board Of Trusteees Of The Leland Stanford Junior University	Mixed allergen compositions and methods for using the same
US11452774B2 (en)	2015-02-20	2022-09-27	The Board Of Trustees Of The Leland Stanford Junior University	Mixed allergen compositions and methods for using the same
US10143742B2 (en)	2015-02-20	2018-12-04	The Board Of Trustees Of The Leland Stanford Junior University	Mixed allergen compositions and methods for using the same
JP6859261B2 (ja)	2015-02-20	2021-04-14	ザ・ボード・オブ・トラスティーズ・オブ・ザ・リーランド・スタンフォード・ジュニア・ユニバーシティ	混合アレルゲン組成物およびそれを使用する方法
TW201709926A (zh) *	2015-04-23	2017-03-16	賽諾菲公司	用於舌下投藥之吡喃葡萄糖基脂ａ及過敏原調配物
US10856567B2 (en)	2016-07-22	2020-12-08	Kari Brown	Baby food products containing allergenic proteins and methods of delivering same
KR102609841B1 (ko) *	2016-12-05	2023-12-06	리액타 바이오테크 리미티드	경구 식품 유발시험 식사 제제
CA3050093A1 (en) *	2017-01-13	2018-07-19	Aimmune Therapeutics, Inc.	Methods of manufacture of nut flours and formulations for oral immunotherapy
BR102017026619A2 (pt)	2017-02-15	2018-10-30	Euroimmun Medizinische Labordiagnostika Ag	ensaio melhorado para a diagnose de alergia a amendoim
CN111465328A (zh)	2017-07-18	2020-07-28	前品牌股份有限公司	制备混合型变应原组合物的方法
JP7498661B2 (ja)	2017-11-02	2024-06-12	ソシエテ・デ・プロデュイ・ネスレ・エス・アー	経口免疫療法の方法
GB201718342D0 (en)	2017-11-06	2017-12-20	Cambridge Allergy Ltd	Allergenic protein formulations for immunotherapy
JP7319351B2 (ja)	2018-07-27	2023-08-01	ソシエテ・デ・プロデュイ・ネスレ・エス・アー	経口免疫療法の単位用量分配システムおよび方法
CN113423282A (zh) *	2018-12-17	2021-09-21	爱沐疗法公司	用于卵口服免疫疗法的制剂、制备方法和用于卵***反应的治疗
CA3123605A1 (en) *	2018-12-20	2020-06-25	Aimmune Therapeutics, Inc.	Peanut oral immunotherapy dosing schedule for missed doses
WO2020154476A1 (en)	2019-01-23	2020-07-30	Before Brands, Inc.	Methods for making mixed allergen compositions
EP3965815A4 (en)	2019-05-10	2023-05-31	Société des Produits Nestlé S.A.	METHOD OF IMPROVING THE QUALITY OF LIFE IN A PEANUT ALLERGY PATIENT
AU2020324553A1 (en) *	2019-08-08	2022-03-24	Evonik Operations Gmbh	Method of preparing a solid dosage form and a lubricant
CA3162040A1 (en) *	2019-12-23	2021-07-01	Bronwyn POLLOCK	Pharmaceutical compositions
KR20230130681A (ko)	2021-01-08	2023-09-12	리제너론 파아마슈티컬스, 인크.	Il-4r 길항제 투여에 의한 땅콩 알레르기를 치료하는방법 및 땅콩 알레르기원 특이적 면역치료를 강화하는 방법
WO2023198674A1 (en)	2022-04-11	2023-10-19	Alk-Abelló A/S	Peanut allergen composition

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3809767A (en) *	1969-05-12	1974-05-07	Griffith Laboratories	Methods of making vegetable protein concentrates
AU1589492A (en)	1991-03-01	1992-10-06	Warner-Lambert Company	Starch-based controlled release compositions
US20120164306A1 (en) *	1993-08-03	2012-06-28	Girsh Leonard S	Process for preparing hypoallergenic and reduced fat foods
JP3445593B2 (ja) *	1994-09-10	2003-09-08	株式会社林原生物化学研究所	ペプチドとその用途
US20020018778A1 (en)	1999-12-06	2002-02-14	Caplan Michael J.	Passive desensitization
WO2001066136A2 (en) *	2000-04-06	2001-09-13	Panacea Pharmaceuticals, Llc.	Microbial delivery system
AU2004216559B2 (en)	2003-02-28	2010-05-27	Alk-Abello A/S	Dosage form having a saccharide matrix
US7820175B2 (en)	2004-03-19	2010-10-26	Herbal Spring, Llc	Herbal therapy for the treatment of food allergy
CA2634094A1 (en) *	2005-12-28	2007-07-05	Teva Pharmaceutical Industries Ltd.	Pharmaceutical formulations of fenofibrate having improved bioavailability
FR2924349B1 (fr) *	2007-12-03	2010-01-01	Dbv Tech	Methode de desensibilitation aux allergenes
SG171752A1 (en)	2008-11-19	2011-07-28	Avantor Performance Mat Inc	Directly compressible granular microcrystalline cellulose based excipient, manufacturing process and use thereof
RU2484813C2 (ru)	2008-12-19	2013-06-20	Мерц Фарма Гмбх Унд Ко. Кгаа	Производные 1-амино-алкилциклогексана для лечения заболеваний, опосредованных тучными клетками
US8329208B2 (en) *	2009-07-28	2012-12-11	Methylation Sciences International Srl	Pharmacokinetics of S-adenosylmethionine formulations
EP2364690A1 (en) *	2010-02-12	2011-09-14	Centro De Ingenieria Genetica Y Biotecnologia	Orally administrable pharmaceutical pellet of epidermal growth factor
JP5800527B2 (ja)	2010-03-30	2015-10-28	日東電工株式会社	安定化医薬組成物、安定化医薬組成物溶液製剤、フィルム状製剤及びフィルム状製剤の製造方法
UY33472A (es) *	2010-06-30	2012-01-31	Novartis Ag	?composiciones farmacéuticas que comprenden monohidrato de lactato de 4-amino-5-fluoro-3-[6-(4-metil-piperazin-1-il)-1hbencimidazol-2-il]-1h-quinolin-2-ona?.
CN101912364B (zh) *	2010-08-09	2015-07-15	刘会梅	银杏内酯b脂质体组合药物
GB201104537D0 (en)	2011-03-17	2011-05-04	Cambridge Entpr Ltd	Treatment for peanut allergy
DK2750705T3 (en) *	2011-08-31	2023-01-23	Perosphere Tech Inc	Methods for effectively and rapidly desensitizing allergic patients
WO2013087119A1 (en)	2011-12-16	2013-06-20	Hal Allergy Holding B.V.	Pharmaceutical formulations and the use thereof for the treatment of peanut allergy
FI3482771T3 (fi)	2013-03-14	2023-04-03	Nestle Sa	Maapähkinäformulaatioiden valmistaminen oraaliseen siedätyshoitoon
US9492535B2 (en)	2013-03-14	2016-11-15	Aimmune Therapeutics, Inc.	Peanut formulations and uses thereof
KR102425265B1 (ko)	2014-08-25	2022-07-26	에이뮨 테라퓨틱스, 인코퍼레이티드	난 단백질 제형 및 이의 제조 방법
CA3050093A1 (en)	2017-01-13	2018-07-19	Aimmune Therapeutics, Inc.	Methods of manufacture of nut flours and formulations for oral immunotherapy
JP7498661B2 (ja)	2017-11-02	2024-06-12	ソシエテ・デ・プロデュイ・ネスレ・エス・アー	経口免疫療法の方法

2014
- 2014-03-12 FI FIEP18213124.3T patent/FI3482771T3/fi active
- 2014-03-12 EP EP18213124.3A patent/EP3482771B1/en active Active
- 2014-03-12 PL PL14776121T patent/PL2968529T3/pl unknown
- 2014-03-12 DK DK14776121.7T patent/DK2968529T3/da active
- 2014-03-12 EP EP21199373.8A patent/EP3998080A1/en active Pending
- 2014-03-12 CN CN201480013792.4A patent/CN105101994B/zh active Active
- 2014-03-12 ES ES18213124T patent/ES2940686T3/es active Active
- 2014-03-12 WO PCT/US2014/024401 patent/WO2014159607A1/en active Application Filing
- 2014-03-12 CA CA2903229A patent/CA2903229A1/en active Pending
- 2014-03-12 CN CN201811093370.9A patent/CN109125283A/zh active Pending
- 2014-03-12 MX MX2015010315A patent/MX2015010315A/es unknown
- 2014-03-12 PT PT147761217T patent/PT2968529T/pt unknown
- 2014-03-12 ES ES14776121T patent/ES2826224T3/es active Active
- 2014-03-12 HU HUE14776121A patent/HUE051831T2/hu unknown
- 2014-03-12 BR BR112015021756-7A patent/BR112015021756B1/pt active IP Right Grant
- 2014-03-12 US US14/207,165 patent/US9198869B2/en active Active
- 2014-03-12 JP JP2016501522A patent/JP6752140B2/ja active Active
- 2014-03-12 SI SI201431687T patent/SI2968529T1/sl unknown
- 2014-03-12 DK DK18213124.3T patent/DK3482771T3/da active
- 2014-03-12 AU AU2014240404A patent/AU2014240404B2/en active Active
- 2014-03-12 EP EP14776121.7A patent/EP2968529B1/en active Active
2015
- 2015-10-13 US US14/881,437 patent/US20160030289A1/en not_active Abandoned
2016
- 2016-05-20 HK HK16105808.3A patent/HK1217660A1/zh unknown
- 2016-09-21 AU AU2016231523A patent/AU2016231523B2/en active Active
2017
- 2017-10-24 US US15/792,716 patent/US10449118B2/en active Active
2018
- 2018-08-30 AU AU2018222980A patent/AU2018222980A1/en not_active Abandoned
2019
- 2019-02-27 JP JP2019034083A patent/JP6891205B2/ja active Active
- 2019-06-26 US US16/453,871 patent/US11141352B2/en active Active
2020
- 2020-04-22 AU AU2020202685A patent/AU2020202685B2/en active Active
2021
- 2021-02-19 JP JP2021025462A patent/JP7454519B2/ja active Active
2022
- 2022-03-17 AU AU2022201858A patent/AU2022201858B2/en active Active
- 2022-09-20 US US17/948,611 patent/US20230120350A1/en active Pending
2023
- 2023-07-04 FI FIC20230022C patent/FIC20230022I1/fi unknown
- 2023-07-07 FR FR23C1026C patent/FR23C1026I2/fr active Active

Also Published As

Publication number	Publication date
WO2014159607A1 (en)	2014-10-02
ES2826224T3 (es)	2021-05-17
AU2014240404B2 (en)	2016-07-21
US20200129378A1 (en)	2020-04-30
FI3482771T3 (fi)	2023-04-03
EP2968529A1 (en)	2016-01-20
CN109125283A (zh)	2019-01-04
CN105101994A (zh)	2015-11-25
EP3998080A1 (en)	2022-05-18
JP2019108357A (ja)	2019-07-04
AU2020202685B2 (en)	2022-01-20
EP3482771A1 (en)	2019-05-15
AU2016231523A1 (en)	2016-10-06
JP6891205B2 (ja)	2021-06-18
US11141352B2 (en)	2021-10-12
EP2968529A4 (en)	2016-10-05
US20140271836A1 (en)	2014-09-18
AU2014240404A1 (en)	2015-09-17
PT2968529T (pt)	2020-11-10
CN105101994B (zh)	2018-10-12
MX2015010315A (es)	2016-04-13
FR23C1026I1 (fr)	2023-10-06
CA2903229A1 (en)	2014-10-02
SI2968529T1 (sl)	2021-03-31
JP7454519B2 (ja)	2024-03-22
AU2022201858B2 (en)	2024-04-04
ES2940686T3 (es)	2023-05-10
JP6752140B2 (ja)	2020-09-09
AU2018222980A1 (en)	2018-09-20
AU2020202685A1 (en)	2020-05-14
BR112015021756A8 (pt)	2019-11-19
EP3482771B1 (en)	2023-01-18
US9198869B2 (en)	2015-12-01
US20230120350A1 (en)	2023-04-20
HK1217660A1 (zh)	2017-01-20
PL2968529T3 (pl)	2021-04-19
US20160030289A1 (en)	2016-02-04
HUE051831T2 (hu)	2021-03-29
BR112015021756A2 (pt)	2017-07-18
FIC20230022I1 (fi)	2023-07-04
US10449118B2 (en)	2019-10-22
AU2022201858A1 (en)	2022-04-07
FR23C1026I2 (fr)	2024-07-26
EP2968529B1 (en)	2020-08-05
AU2016231523B2 (en)	2018-05-31
US20180042816A1 (en)	2018-02-15
JP2016512537A (ja)	2016-04-28
JP2021073321A (ja)	2021-05-13
BR112015021756B1 (pt)	2023-01-10
DK2968529T3 (da)	2020-10-12

Publication	Publication Date	Title
DK3482771T3 (da)	2023-03-20	Fremstilling af jordnøddeformuleringer til oral desensibilisering
DK2961766T3 (da)	2019-07-15	Kvantificering af vaccinesammensætninger
DK3454346T3 (da)	2021-11-01	Anordning til cylotronfremstilling af technetium-99m
DK3611262T3 (da)	2021-01-25	Fremgangsmåder til sekvensering af immunrepertoire
BR112016003454A2 (pt)	2017-08-01	Uso de composto de metil bardoxolona
DK3080100T3 (da)	2023-02-06	Hæmmere af lysinspecifik demethylase-1
DK3157508T3 (da)	2021-02-15	Fast oral doseringsform af lipofile forbindelser
DK2845905T3 (da)	2021-06-14	Fremstilling af oligosaccharider
DK3049441T3 (da)	2020-02-03	Anti-PDL1-antistofformuleringer
DK3239134T3 (da)	2021-02-22	Pyridonamider som modulatorer af natriumkanaler
DK3725778T3 (da)	2021-09-20	Formuleringer af enzalutamid
DK2961388T3 (da)	2019-07-08	Kombinationer af lægemidler
DK2981255T3 (da)	2022-11-14	Terapeutiske anvendelser af empagliflozin
DK3185853T3 (da)	2024-02-26	Inhalerbare pulverformuleringer af alginatoligomerer
DK2968221T3 (da)	2019-08-05	Farmaceutisk sammensætning af s-ketaminhydrochlorid
DK3010895T3 (da)	2017-11-20	Fremgangsmåde til fremstilling af 4-propargyleret aminobenzoxazinoner
DK3079669T3 (da)	2020-11-02	Sammensætninger med forsinket frigivelse af linaclotid
DK3300015T3 (da)	2019-11-18	System til fremstilling af individuelle formuleringer til individer
DK3106150T3 (da)	2021-11-01	Forbedrede farmaceutiske sammensætninger af pimobendan
DK3010352T3 (da)	2021-03-08	Fremgangsmåde til fremstilling af fodertilsætning
DK3003306T3 (da)	2020-11-30	Gentagen indgivelse af ikke-immunosupressive antigenspecifikke immunterapeutika
DK3680000T3 (da)	2024-04-02	Fremgangsmåder til oprensning af antistoffer
DK2919777T3 (da)	2020-03-09	Transmukosal afgivelse af tocotrienol
DK2931313T3 (da)	2019-07-15	Opløsningsformuleringer af manipulerede anti-il-23p19-antistoffer
DK2965026T3 (da)	2019-10-28	Generering af slushice